FDA looks at full approval for d4T. Food and Drug Administration.
D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D018119:Stavudine / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors; D018119:Stavudine